Today's Top Stories
View all
More Stories
View allTestosterone and the AC- More Muscle, More Questions
Is testosterone use associated with more ACL tears?
The Heart Has a Vote in Shoulder Replacement Timing
Is a history of myocardial infarction incompatible with shoulder surgery?
Centinel Spine® Receives MDR Certification for prodisc® L Lumbar Total Disc Replacement System
Centinel Spine®, LLC today announced that its prodisc L Lumbar TDR system has received certification under the European Union Medical Device Regulation (MDR).
NervGen Receives FDA Breakthrough Therapy Designation for NVG-291 in Chronic Spinal Cord Injury
Breakthrough Therapy designation granted based on FDA’s review of safety and efficacy data from the chronic cohort of the Phase 1b/2a CONNECT SCI study.
Naitive® Receives FDA 510(k) Clearance for OsteoSight™ Spine, Extending AI-Enabled Opportunistic Bone Health Assessment to Spine and Chest X-rays
Naitive Technologies today announced that it has received FDA 510(k) for OsteoSight Spine.
SINTX Technologies Advances SiN/PEEK 3D Printing Platform Toward Personalized Orthopedic Implant Commercialization
Company completes additive manufacturing facility buildout, advances proprietary silicon nitride–PEEK technology, expands leadership and targets initial product availability in 2027
Bioventus Announces Q3 Results and Strategic Buyer Interest
What’s Bioventus worth to a strategic buyer?
SSRIs and Hip Replacement Risk With a Dose of Uncertainty
Is anti-depressant use associated with hip arthroplasty complications?
THINK Surgical Receives the 2026 AAHKS Industry Innovation Award
The American Association of Hip and Knee Surgeons (AAHKS) recognized THINK Surgical as the 2026 AAHKS Industry Innovation Award recipient during the 2026 AAHKS Annual Meeting in Dallas, Texas.
Scoliosis Screening Gets a Stronger Case After 30 Years
Can scoliosis screening reduce AIS surgeries?
Spineology Announces New OptiMesh® TLIF System, Expanding Surgical Access and Procedural Versatility
New system enhances the OptiMesh platform, giving surgeons greater flexibility to incorporate expandable implant technology into their preferred TLIF approach.
RESTEM Receives FDA Clearance of IND for Phase 1/2 Clinical Trial of Restem-X in Knee Osteoarthritis
Phase 1/2 clinical trial anticipated to be initiated in the first half of 2027.
